HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Turlakow, A. Articles by Larson, S. M. Search for Related Content PubMed PubMed Citation Articles by Turlakow, A. Articles by Larson, S. M.

Peritoneal Carcinomatosis: Role of ¹⁸F-FDG PET

Department of Nuclear Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Peritoneal carcinomatosis can be difficult to diagnose, as CT is insensitive, with peritoneal biopsy and lavage often subject to problems of sampling error. The aim of our study was to evaluate the role of ¹⁸F-FDG PET in detecting peritoneal carcinomatosis in patients with stomach, ovarian, and adrenal cancer and mesothelioma and to compare the results with CT scans in the same patient group. Our secondary aim was to identify characteristic patterns of abdominal ¹⁸F-FDG uptake in biopsy-proven peritoneal disease and to correlate these patterns with available histologic and anatomic findings after surgery and structural imaging. Methods: The medical records of 88 patients with stomach (n = 48), ovarian (n = 13), and adrenal cancer (n = 6) and mesothelioma (n = 21) were reviewed for the presence of peritoneal tumor on ¹⁸F-FDG PET and CT scans. The results were correlated with either contemporaneous peritoneal biopsy or ascitic aspirate or with radiographic or clinical follow-up if histology was negative or unavailable. Of 24 patients with suspected peritoneal tumor, 17 had biopsy-proven findings of peritoneal disease. Results: Of the 24 patients with suspected peritoneal tumor, ¹⁸F-FDG PET was positive in 14 patients, with 1 of these scans being false-positive, CT was positive in 10 patients, and either PET or CT was positive in 18 patients. This yielded sensitivities of 57% (13/23), 42% (10/23), and 78% (18/23), with uniformly high positive predictive values of 93% (13/14), 100% (10/10), and 95% (18/19), respectively. We identified 2 distinctly abnormal scintigraphic patterns of focal and uniform ¹⁸F-FDG uptake corresponding to nodular and diffuse peritoneal disease on pathologic examination. Conclusion: ¹⁸F-FDG PET adds to conventional imaging in the staging of peritoneal carcinomatosis. It is also a useful diagnostic tool when peritoneal biopsy is either unavailable or inappropriate. We have identified 2 distinct scintigraphic patterns that appear to predict the presence of either nodular or diffuse peritoneal pathology.

Key Words: peritoneal carcinomatosis • ¹⁸F-FDG PET • scintigraphic patterns

This article has been cited by other articles:

				P. Gupta The straight line sign. Radiology, August 1, 2006; 240(2): 611 - 612. [Full Text] [PDF]

				J. S. Lim, M. J. Yun, M.-J. Kim, W. J. Hyung, M.-S. Park, J.-Y. Choi, T.-S. Kim, J. D. Lee, S. H. Noh, and K. W. Kim CT and PET in Stomach Cancer: Preoperative Staging and Monitoring of Response to Therapy RadioGraphics, January 1, 2006; 26(1): 143 - 156. [Abstract] [Full Text] [PDF]

				N. Pandit-Taskar Oncologic Imaging in Gynecologic Malignancies J. Nucl. Med., November 1, 2005; 46(11): 1842 - 1850. [Abstract] [Full Text] [PDF]

				Y T Lee, E K W Ng, L C T Hung, S C S Chung, J Y L Ching, W Y Chan, W C Chu, and J J Sung Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients Gut, November 1, 2005; 54(11): 1541 - 1545. [Abstract] [Full Text] [PDF]

				N. Subhas, P. V. Patel, H. K. Pannu, H. A. Jacene, E. K. Fishman, and R. L. Wahl Imaging of Pelvic Malignancies with In-Line FDG PET-CT: Case Examples and Common Pitfalls of FDG PET RadioGraphics, July 1, 2005; 25(4): 1031 - 1043. [Abstract] [Full Text] [PDF]

				J.-H. Kim, J. Czernin, M. S. Allen-Auerbach, B. S. Halpern, B. J. Fueger, J. R. Hecht, O. Ratib, M. E. Phelps, and W. A. Weber Comparison Between 18F-FDG PET, In-Line PET/CT, and Software Fusion for Restaging of Recurrent Colorectal Cancer J. Nucl. Med., April 1, 2005; 46(4): 587 - 595. [Abstract] [Full Text] [PDF]